Furthermore, PARP14 promoted pancreatic cancer cell proliferation, anti‐apoptosis, and GEM (gemcitabine) resistance via its relationship with the NF‐κB signaling pathway, which agrees our research that it has high potential to be an effective drug‐based target.51 The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.